Media headlines about Burcon NutraScience (NASDAQ:BUR) (TSE:BU) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Burcon NutraScience earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.3299859061927 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Separately, ValuEngine raised Burcon NutraScience from a “strong sell” rating to a “sell” rating in a report on Friday, September 15th.

Shares of Burcon NutraScience (BUR) opened at $0.53 on Tuesday. Burcon NutraScience has a fifty-two week low of $0.40 and a fifty-two week high of $2.13. The company has a current ratio of 4.30, a quick ratio of 4.30 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $19.94, a PE ratio of -4.42 and a beta of 0.71.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://theolympiareport.com/2017/12/26/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-burcon-nutrascience-bur-share-price.html.

Burcon NutraScience Company Profile

Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.

Insider Buying and Selling by Quarter for Burcon NutraScience (NASDAQ:BUR)

Receive News & Ratings for Burcon NutraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience and related companies with MarketBeat.com's FREE daily email newsletter.